[33] Referencias [editar] de Graaf, Chris
However, the fine print matters
SGLT2is as Foundational Therapy in Adults with CKD There was a clear consensus that SGLT2is should be positioned as foundational therapy in adults with CKD and T2D, independent of BMI and in particular in the presence of HF, given their consistent kidney protective benefits and well-established mechanisms of action [20,21,22]
Circ Res 116:15611578 Sikiric P, Seiwerth S, Grabarevic Z, Rucman R, Petek M, Jagic V, Turkovic B, Rotkvic I, Mise S, Zoricic I et al (1997) Pentadecapeptide BPC 157 positively affects both non-steroidal anti-inflammatory agent-induced gastrointestinal lesions and adjuvant arthritis in rats
It also recycles other antioxidants, helping maintain overall redox balance
102 ZEB1 silencing induces E-cadherin expression and decreases susceptibility to ferroptosis in HNC cells, while ZEB1 overexpression increases susceptibility to ferroptosis